Cargando…
Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
Hemangioma (HA) is one of the most common benign vascular tumors among children. Propranolol is used as the first-line treatment for hemangioma and is a non-selective blocker of the β-adrenergic receptor. β-elemene is a compound extracted from Rhizoma zedoariae and has been approved for the treatmen...
Autores principales: | Wang, Zhenyu, Chen, Yinxian, Yang, Lin, Yao, Dunbiao, Shen, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349565/ https://www.ncbi.nlm.nih.gov/pubmed/37456875 http://dx.doi.org/10.7717/peerj.15643 |
Ejemplares similares
-
Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
por: Yuan, Weili, et al.
Publicado: (2021) -
Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)